Crossmark

A pilot randomised controlled trial of the Tailored Intervention for people with moderate-to-severe Chronic Obstructive Pulmonary Disease and Co-morbidities delivered by Pharmacists and Consultant respiratory Physicians (TICC-PCP)

Crossref DOI link: https://doi.org/10.1038/s41533-025-00451-9

Published Online: 2025-10-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lowrie, Richard

Anderson, David

Sheikh, Aziz

Moir, Jane

McPherson, Andrew

Stanley, Bethany

Cameron, Gillian

Attwood, Lynda

Noble, Donald

Rankine, Elaine

Anderson, Jennifer

Greenlaw, Nicola

Hughes, Fiona

McIntosh, Emma

Achiaw, Samuel Owusu

Tait, Lesley Anne

Wood, Karen

Scobie, Hannah

Mair, Frances S.
Funding

Funding for this research was provided by:

Chief Scientist Office (HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27, HIPS/19/27)
License Information

Text and Data Mining valid from 2025-10-24

Version of Record valid from 2025-10-24
More Information

Article History

Received: 10 June 2025

Accepted: 7 September 2025

First Online: 24 October 2025

Competing interests

: The authors declare no competing interests.

: Approved by the South East Scotland Research Ethics Committee 01. REC reference: 20/SS/0093, September 2020.

: All participants provided written informed consent for publishing.

Document is current

Any future updates will be listed below